Under what circumstances, if any, should providers be required to tell patients about the provider's receipt of consulting payments from pharmaceutical companies or medical device manufacturers? Would a patient ever be able to bring a successful informed consent case against a provider who fails to make such a disclosure? Are there potential downsides to requiring providers to disclose such information as part of the informed consent process?